ADIL (Adial Pharmaceuticals) Cyclically Adjusted FCF per Share: $-262.23 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADIL Adial Pharmaceuticals Inc ADIL
30 GF Score
Price $5.94
! 1 Warning Sign
View Full Analysis

What is Adial Pharmaceuticals Cyclically Adjusted FCF per Share?

Adial Pharmaceuticals ADIL +2.59% 30 Cyclically Adjusted FCF per Share is $-262.23 as of Jun. 2026. GuruFocus rates ADIL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Adial Pharmaceuticals's adjusted free cash flow per share for the three months ended in Jun. 2026 was $-1.377. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-262.23 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-27), Adial Pharmaceuticals's current stock price is $5.94. Adial Pharmaceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $-262.23. Adial Pharmaceuticals's Cyclically Adjusted Price-to-FCF of today is .


Adial Pharmaceuticals  (NAS:ADIL) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Adial Pharmaceuticals Cyclically Adjusted FCF per Share Related Terms


Adial Pharmaceuticals Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Adial Pharmaceuticals's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adial Pharmaceuticals Cyclically Adjusted FCF per Share Chart

Adial Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -268.32

Adial Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -268.32 -266.16 -262.23

ADIL vs PULM, KAPA, ACXP: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Adial Pharmaceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adial Pharmaceuticals Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adial Pharmaceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Adial Pharmaceuticals's Cyclically Adjusted Price-to-FCF falls into.


ADIL
30GF Score
Adial Pharmaceuticals Inc ADIL
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adial Pharmaceuticals Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Adial Pharmaceuticals's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-1.377/333.9520*333.9520
=-1.377

Current CPI (Jun. 2026) = 333.9520.

Adial Pharmaceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 -10.625 243.801 -14.554
201706 -18.875 244.955 -25.733
201709 -15.222 246.819 -20.596
201712 -13.556 246.524 -18.364
201803 -26.750 249.554 -35.797
201806 -18.900 251.989 -25.047
201809 -110.111 252.439 -145.666
201812 -100.364 251.233 -133.409
201903 -132.385 254.202 -173.918
201906 -71.250 256.143 -92.894
201909 -107.813 256.759 -140.226
201912 -103.118 256.974 -134.008
202003 -107.353 258.115 -138.894
202006 -54.722 257.797 -70.887
202009 -100.409 260.280 -128.830
202012 -113.652 260.474 -145.712
202103 -114.960 264.877 -144.939
202106 -115.607 271.696 -142.097
202109 -110.313 274.310 -134.298
202112 -71.909 278.802 -86.133
202203 -67.486 287.504 -78.389
202206 -90.615 296.311 -102.126
202209 -83.024 296.808 -93.414
202212 -42.707 296.797 -48.053
202303 -54.738 301.836 -60.562
202306 -42.089 305.109 -46.068
202309 -29.596 307.789 -32.112
202312 -18.254 306.746 -19.873
202403 -13.780 312.332 -14.734
202406 -12.862 314.175 -13.672
202409 -7.270 315.301 -7.700
202412 -5.658 315.605 -5.987
202503 -6.050 319.799 -6.318
202506 -4.118 322.561 -4.263
202509 -2.067 324.800 -2.125
202512 -1.193 324.054 -1.229
202603 -1.177 330.213 -1.190
202606 -1.377 333.952 -1.377

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-262.23 mean?
Adial Pharmaceuticals (ADIL) has a Cyclically Adjusted FCF per Share of $-262.23 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Adial Pharmaceuticals and its competitors.
Is Adial Pharmaceuticals' Cyclically Adjusted FCF per Share too high?
Adial Pharmaceuticals' current Cyclically Adjusted FCF per Share is $-262.23. Overall, Adial Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Adial Pharmaceuticals' Cyclically Adjusted FCF per Share compare to PULM and KAPA?
Adial Pharmaceuticals' Cyclically Adjusted FCF per Share of $-262.23 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Adial Pharmaceuticals and its competitors. Adial Pharmaceuticals's current Cyclically Adjusted FCF per Share is $-262.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adial Pharmaceuticals stock overvalued right now?
Adial Pharmaceuticals (ADIL) has a current Cyclically Adjusted FCF per Share of $-262.23. The current Cyclically Adjusted FCF per Share is $-262.23. Adial Pharmaceuticals' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Adial Pharmaceuticals (ADIL), the current Cyclically Adjusted FCF per Share is $-262.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adial Pharmaceuticals Business Description

Address 4870 Sadler Road, Suite 300, Glen Allen, VA, USA, 23060
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
30GF Score

Get the complete analysis for ADIL

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.94
Price